127273-06-7Relevant articles and documents
GLP RECEPTOR AGONISTS
-
Page/Page column 30; 33, (2021/09/26)
The disclosures herein relate to novel compounds of formula (1 ): and salts thereof, wherein Q, W, X, Y, Z, AA1, AA2, AA3, AA4, AA5, AA6, AA7, AA8, AA9, LysR, R1, R2 and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with Glucagon-like peptide (GLP) receptors.
Tetrazole analogues of aspartic, glutamic and α-aminoadipic acids and their derivatives with tetrazole ring in side chains useful for solid-phase peptide synthesis
Manturewicz,Grzonka
, p. 2121 - 2131 (2008/09/18)
Tetrazole analogues of Fmoc-aspartic, -glutamic and -α-aminoadipic acids with acidic tetrazolyl group in side chains suitable for solid-phase peptide synthesis were obtained. Moreover, the appropriate derivatives of aspartic and glutamic acids containing tetrazole ring methylated in position N1 or N2 were synthesized as well.